跳至主要内容
临床试验/NL-OMON42741
NL-OMON42741已完成不适用

A randomized, double blind, placebo-controlled study on the effect of 3 months treatment with the analgesic tapentadol on conditioned pain modulation (CPM) and pain relief in patients with chronic low back pain - LCAT

eids Universitair Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age: 18 - 75 years.;- Sex: Either sex.
  • - American Society of Anesthesiologists class 1 and 2 patients, 18 - 75 years; BMI < 40 kg/m2, and ability to give informed consent. CLBP for > 3-months with a pain score of 3 or more on a numerical rating scale.

排除标准

  • Unable to give written informed consent; medical disease such as pulmonary, renal, liver, cardiac, gastro-intestinal, vascular disease; (iii) allergy to study medication; (iv) history of illicit drug abuse or alcohol abuse; (v) history of psychosis; (vi) epilepsy; (vii) pregnancy and/or lactation; (viii) strong opioids and benzodiazepine use; (ix) previous extensive spinal surgery or spinal surgery in the past 6 months; (x) serious spinal pathology and (xi) diagnosed neurological disease.

研究者

相似试验